triallength wrongkeyrs

Sex

Visit (Number) vs Psychomotor Vigilance Test (PVT) Trial Number
N Mean StdDev Median Min Max Unknown Total
Baseline (BL) - - - - - - 1,516 1,516
Clinical Evaluation (CE) - - - - - - 1,516 1,516
Diagnostic Visit (DX) 1,199 53.7 ± 10.2 52.0 31.0 72.0 317 1,516
CPAP Titration Visit (CPAP) - - - - - - 1,516 1,516
Two Month Post-CPAP Neurocognitive Visit (2M) 877 55.6 ± 10.3 54.0 33.0 74.0 639 1,516
Four Month Post-CPAP Neurocognitive Visit (4M) - - - - - - 1,516 1,516
Six Month Post-CPAP Neurocognitive Visit (6M) 848 57.6 ± 10.2 56.0 35.0 76.0 668 1,516
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,199 53.7 ± 10.2 52.0 31.0 72.0 317 1,516
Male 767 53.7 ± 10.1 52.0 31.0 72.0 191 958
Female 432 53.6 ± 10.4 51.0 31.0 72.0 126 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 877 55.6 ± 10.3 54.0 33.0 74.0 639 1,516
Male 569 55.8 ± 10.2 54.0 33.0 74.0 389 958
Female 308 55.0 ± 10.3 53.0 33.0 74.0 250 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Trial Number
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 848 57.6 ± 10.2 56.0 35.0 76.0 668 1,516
Male 550 57.9 ± 10.2 56.0 35.0 76.0 408 958
Female 298 57.0 ± 10.2 55.5 35.0 76.0 260 558
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,199 53.7 ± 10.2 52.0 31.0 72.0 317 1,516
Native American 20 57.1 ± 8.9 56.5 41.0 72.0 8 28
Asian 71 55.5 ± 11.0 52.0 31.0 72.0 18 89
Black 115 53.7 ± 9.4 52.0 41.0 72.0 57 172
Hispanic 83 52.9 ± 11.1 52.0 31.0 72.0 33 116
White 902 53.5 ± 10.2 51.0 31.0 72.0 200 1,102
Other 8 56.4 ± 10.5 52.0 41.0 71.0 1 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 877 55.6 ± 10.3 54.0 33.0 74.0 639 1,516
Native American 13 60.3 ± 8.8 63.0 43.0 74.0 15 28
Asian 48 56.7 ± 11.4 54.0 33.0 74.0 41 89
Black 76 56.1 ± 9.4 54.0 43.0 74.0 96 172
Hispanic 65 55.1 ± 11.5 54.0 33.0 74.0 51 116
White 672 55.3 ± 10.1 54.0 33.0 74.0 430 1,102
Other 3 63.7 ± 10.0 63.0 54.0 74.0 6 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Trial Number
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 848 57.6 ± 10.2 56.0 35.0 76.0 668 1,516
Native American 13 60.8 ± 7.9 65.0 45.0 75.0 15 28
Asian 50 58.4 ± 11.4 56.0 35.0 76.0 39 89
Black 75 58.3 ± 9.7 56.0 45.0 76.0 97 172
Hispanic 61 57.3 ± 11.1 56.0 35.0 76.0 55 116
White 646 57.4 ± 10.1 56.0 35.0 76.0 456 1,102
Other 3 65.7 ± 10.0 65.0 56.0 76.0 6 9